Clinical Trial

Polysomnographic Titration of Non-invasive Ventilation in Motor Neurone Disease

Study acronym: 3TLA
Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated June 23, 2022 (before its estimated February 28, 2026 completion). Its status may not reflect the trial's current state.
Summary
A two-arm, individual participant randomised controlled, assessor-blinded trial in 7 MND care centres across Australia will be undertaken.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2021-11-25.
Status change: Not Yet Recruiting → Recruiting 2022-06-19
Trial Details
NCT Number NCT05136222
Lead Sponsor University of Melbourne
Collaborators: Austin Hospital, Melbourne Australia, Institute for Breathing and Sleep, Australia, Royal Prince Alfred Hospital, Sydney, Australia, Macquarie University, Australia, Macquarie Health, Western Sydney Local Health District, Flinders Medical Centre, Sir Charles Gairdner Hospital, The Prince Charles Hospital, Monash University, Motor Neurone Disease Australia, FightMND, Australian Motor Neurone Disease Registry, Calvary Bethlehem, Perron Institute for Neurological and Translational Science
Conditions Motor Neuron Disease / Amyotrophic Lateral Sclerosis
Enrollment 244 participants
Start Date 2021-12-15
Primary Completion 2026-02-28 (estimated)
Study Completion 2028-02-28 (estimated)
Updated on ClinicalTrials.gov 2022-06-23